These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 12868117)

  • 41. Licochalcone A inhibits the growth of colon carcinoma and attenuates cisplatin-induced toxicity without a loss of chemotherapeutic efficacy in mice.
    Lee CK; Son SH; Park KK; Park JH; Lim SS; Kim SH; Chung WY
    Basic Clin Pharmacol Toxicol; 2008 Jul; 103(1):48-54. PubMed ID: 18484961
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hydration with 15 mEq Magnesium Is Effective at Reducingthe Risk for Cisplatin-induced Nephrotoxicity in Patients Receiving Cisplatin (≥50 mg/m2) Combination Chemotherapy.
    Yamamoto Y; Watanabe K; Tsukiyama I; Yabushita H; Matsuura K; Wakatsuki A
    Anticancer Res; 2016 Apr; 36(4):1873-7. PubMed ID: 27069173
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protective effect of captopril against cisplatin-induced nephrotoxicity in rats.
    El-Sayed el-SM; Abd-Ellah MF; Attia SM
    Pak J Pharm Sci; 2008 Jul; 21(3):255-61. PubMed ID: 18614421
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sodium-wasting nephropathy caused by cisplatin in esophageal cancer.
    Abdelghani L; Modha K; Albaddawi E; Subramanian S
    J Support Oncol; 2008; 6(7):305-6. PubMed ID: 18847072
    [No Abstract]   [Full Text] [Related]  

  • 45. [Magnesium metabolism from the nephrologic viewpoint (a review)].
    Wüstenberg PW
    Z Urol Nephrol; 1972 Apr; 65(4):241-57. PubMed ID: 4559229
    [No Abstract]   [Full Text] [Related]  

  • 46. Nursing measures in the prevention and treatment of renal cell damage associated with cisplatin administration.
    Evans S
    Cancer Nurs; 1991 Apr; 14(2):91-7. PubMed ID: 2044066
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Renal complications of cis-diamminedichloroplatinum.
    Nitschke R
    Ann Clin Lab Sci; 1981; 11(5):392-6. PubMed ID: 7199273
    [TBL] [Abstract][Full Text] [Related]  

  • 48. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants.
    Hensley ML; Hagerty KL; Kewalramani T; Green DM; Meropol NJ; Wasserman TH; Cohen GI; Emami B; Gradishar WJ; Mitchell RB; Thigpen JT; Trotti A; von Hoff D; Schuchter LM
    J Clin Oncol; 2009 Jan; 27(1):127-45. PubMed ID: 19018081
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of curcumin on inflammation and oxidative stress in cisplatin-induced experimental nephrotoxicity.
    Kuhad A; Pilkhwal S; Sharma S; Tirkey N; Chopra K
    J Agric Food Chem; 2007 Dec; 55(25):10150-5. PubMed ID: 18001039
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.
    Lanvers-Kaminsky C; Krefeld B; Dinnesen AG; Deuster D; Seifert E; Würthwein G; Jaehde U; Pieck AC; Boos J
    Pediatr Blood Cancer; 2006 Aug; 47(2):183-93. PubMed ID: 16302218
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Re: Sodium thiosulfate in cisplatin overdose by Erdlenbruch B et al., Med Pediatr Oncol 2002;38:349-352.
    Bleyer A; Alberts DS
    Med Pediatr Oncol; 2003 Jun; 40(6):413; author reply 414. PubMed ID: 12692822
    [No Abstract]   [Full Text] [Related]  

  • 52. Xanthorrhizol has a potential to attenuate the high dose cisplatin-induced nephrotoxicity in mice.
    Kim SH; Hong KO; Hwang JK; Park KK
    Food Chem Toxicol; 2005 Jan; 43(1):117-22. PubMed ID: 15582203
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Meta-analysis of the efficacy of amifostine in the prevention of cisplatin ototoxicity.
    Duval M; Daniel SJ
    J Otolaryngol Head Neck Surg; 2012 Oct; 41(5):309-15. PubMed ID: 23092832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduction of cisplatin-induced nephrotoxicity by pyrazolone compounds, derivatives of tetrahydroindazolonedicarboxylic acid.
    Marijic VF; Makarevic J; Stojkovic R; Kalinic L; Katalenic D; Radacic M
    Methods Find Exp Clin Pharmacol; 2008 Nov; 30(9):675-80. PubMed ID: 19229375
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nephrotoxicity of cancer treatment.
    Lydon J
    Oncol Nurs Forum; 1986; 13(2):68-77. PubMed ID: 3633578
    [No Abstract]   [Full Text] [Related]  

  • 56. Thea sinensis melanin prevents cisplatin-induced nephrotoxicity in mice.
    Hung YC; Huang GS; Lin LW; Hong MY; Se PS
    Food Chem Toxicol; 2007 Jul; 45(7):1123-30. PubMed ID: 17303299
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity.
    Ries F; Klastersky J
    Am J Kidney Dis; 1986 Nov; 8(5):368-79. PubMed ID: 3538860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cisplatin: a review of toxicities and therapeutic applications.
    Barabas K; Milner R; Lurie D; Adin C
    Vet Comp Oncol; 2008 Mar; 6(1):1-18. PubMed ID: 19178659
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low renal toxicity of lipoplatin compared to cisplatin in animals.
    Devarajan P; Tarabishi R; Mishra J; Ma Q; Kourvetaris A; Vougiouka M; Boulikas T
    Anticancer Res; 2004; 24(4):2193-200. PubMed ID: 15330160
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Disorders of calcium-, phosphorus-, and magnesium balance].
    Schmidt-Gayk H; Tschöpe W; Stengel R; Wiedemann J; Ritz E
    ZFA (Stuttgart); 1977 Jun; 53(17):978-85. PubMed ID: 888534
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.